Latest Apnea-hypopnea index Stories
Obstructive sleep apnea, in which people stop breathing for short periods while sleeping, affects about 5% of Canadian adults aged 45 years or older and can negatively affect health.
ACP’s new evidence-based guideline recommends sleep study for individuals with unexplained daytime sleepiness.
A new study with more than 8,500 Canadian patients revealed a link between obstructive sleep apnea (OSA) and the onset of diabetes. The study was the largest one of its kind to date and the results confirmed what earlier studies revealed with smaller and shorter follow-up periods.
THE REMEDE SYSTEM RECOGNIZED AS 2014 BEST INNOVATION AT CRT CONFERENCE MINNEAPOLIS, March 12, 2014 /PRNewswire/ -- Respicardia(®), Inc., a developer of implantable therapies to improve
Obstructive sleep apnea (OSA) generally is associated with increased risk for cardiovascular (CV) disease.
Results published in a new study in the Jan. 9 issue of the New England Journal of Medicine report that mild electronic stimulation therapy to the upper airway during sleep is effective in reducing obstructive sleep apnea (OSA).
UH Case Medical Center one of U.S. and European clinical trial sites showing marked improvements for sleep apnea sufferers CLEVELAND, Jan.
A new study suggests that obstructive sleep apnea severity is higher in African-American men in certain age ranges, even after controlling for body mass index (BMI).
In a study to be presented on February 15 between 8 a.m., and 10 a.m. PST, at the Society for Maternal-Fetal Medicine's annual meeting, The Pregnancy Meeting ™, in San Francisco, researchers will report findings that women with obstructive sleep apnea (OSA) and cardiac symptoms have a 31 percent incidence of cardiac dysfunction.
For individuals with obstructive sleep apnea traveling to higher altitudes (which may exacerbate symptoms), use of a combination therapy resulted in improvement in symptoms including reduced insomnia and better control of sleep apnea.
- Growing in low tufty patches.